Personalized Decision Making for Biopsies in Prostate Cancer Active Surveillance Programs

por Tomer, Anirudh, Rizopoulos, Dimitris, Nieboer, Daan, Drost, Frank-Jan, Roobol, Monique J., Steyerberg, Ewout W.
Publicado 2019

Can active surveillance really reduce the harms of overdiagnosing prostate cancer? A reflection of real life clinical practice in the PRIAS study

por Drost, Frank-Jan H., Rannikko, Antti, Valdagni, Riccardo, Pickles, Tom, Kakehi, Yoshiyuki, Remmers, Sebastiaan, van der Poel, Henk G., Bangma, Chris H., Roobol, Monique J.
Publicado 2018

Reduction of MRI-targeted biopsies in men with low-risk prostate cancer on active surveillance by stratifying to PI-RADS and PSA-density, with different thresholds for significant...

por Schoots, Ivo G., Osses, Daniel F., Drost, Frank-Jan H., Verbeek, Jan F. M., Remmers, Sebastiaan, van Leenders, Geert J. L. H., Bangma, Chris H., Roobol, Monique J.
Publicado 2018

Prostate cancer risk assessment by the primary care physician and urologist: transabdominal- versus transrectal ultrasound prostate volume-based use of the Rotterdam Prostate Cance...

por de Vos, Ivo I., Drost, Frank-Jan H., Bokhorst, Leonard P., Alberts, Arnout R., van Gelder, Martine, Herman, Erik M., Boswinkel, Wouter D., Bangma, Chris H., Roobol, Monique J.
Publicado 2023

Prostate cancer upgrading with serial prostate magnetic resonance imaging and repeat biopsy in men on active surveillance: are confirmatory biopsies still necessary?

por Osses, Daniël F., Drost, Frank‐Jan H., Verbeek, Jan F.M., Luiting, Henk B., van Leenders, Geert J.L.H., Bangma, Chris H., Krestin, Gabriel P., Roobol, Monique J., Schoots, Ivo G.
Publicado 2020